Global Killer-cell immunoglobulin-like receptors (KIRs) Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Killer-cell immunoglobulin-like receptors (KIRs) market size was valued at US$ 88.49 million in 2025 and is forecast to a readjusted size of US$ 157 million by 2032 with a CAGR of 8.4% during review period.
Killer-cell immunoglobulin-like receptors (KIRs) are a family of transmembrane glycoprotein receptors mainly expressed on natural killer cells and subsets of T cells, and the term also refers to the related commercial products and services built around KIR proteins, KIR genes, ligand recognition, and functional immune analysis. They are not visible stand-alone devices, but molecular receptors located on the cell membrane, typically composed of extracellular immunoglobulin-like domains, a transmembrane region, and a cytoplasmic tail. Structurally, KIRs can contain two or three extracellular immunoglobulin-like domains, while functionally they include inhibitory and activating receptor types. Commercial products include genotyping kits, sequencing and testing services, flow cytometry antibodies, conjugated antibodies, recombinant proteins, plasmids, cell models, and reference antibodies for drug discovery. Their mechanism is based on recognizing human leukocyte antigen-related ligands and regulating natural killer cell cytotoxicity, immune tolerance, and immune surveillance. Major use scenarios include transplant immunogenetics, natural killer cell research, oncology immunology, immune phenotyping, therapeutic antibody discovery, cell therapy development, and reproductive immunology research.
Market growth opportunities are mainly supported by three demand streams. First, transplant immunogenetics and cell therapy are increasing the need to understand donor-recipient immune background, which supports demand for genotyping, receptor-ligand analysis, and immune risk assessment. Second, the rising importance of natural killer cells in oncology, infectious disease, and autoimmune research is expanding demand for flow cytometry antibodies, recombinant proteins, and functional validation materials. Third, more specific receptor targets are moving part of the market closer to translational development, especially in therapeutic antibody programs, immune monitoring, and potential companion testing workflows.
The main market challenges are clinical evidence, standardization, and commercial scale. These products are used mostly by specialized laboratories, transplant centers, academic institutes, and drug developers, so the customer base is much narrower than that of routine clinical diagnostics. Complex polymorphism, haplotype variation, gene copy number differences, and platform-specific interpretation create technical barriers in quality control and reporting. The value of routine KIR-based decision-making still requires stronger prospective evidence, so near-term market development should be assessed as steady professional adoption rather than mass-market expansion.
Downstream demand is expected to shift from single-product purchasing toward integrated solutions. Transplant-related users will increasingly combine genotyping, ligand matching, and long-term outcome data. Oncology immunology users will focus more on receptor expression, immune-cell functional status, and treatment response monitoring. Drug developers will require higher target specificity, antibody affinity validation, cytotoxicity mechanism studies, and clinical sample-based evidence. Faster-growing product categories are likely to include high-throughput typing, conjugated antibody panels, recombinant proteins, reference antibodies, and testing services designed for clinical research.
This report is a detailed and comprehensive analysis for global Killer-cell immunoglobulin-like receptors (KIRs) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Killer-cell immunoglobulin-like receptors (KIRs) market size and forecasts, in consumption value ($ Million), 2021-2032
Global Killer-cell immunoglobulin-like receptors (KIRs) market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Killer-cell immunoglobulin-like receptors (KIRs) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Killer-cell immunoglobulin-like receptors (KIRs) market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Killer-cell immunoglobulin-like receptors (KIRs) market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Killer-cell immunoglobulin-like receptors (KIRs) are a family of transmembrane glycoprotein receptors mainly expressed on natural killer cells and subsets of T cells, and the term also refers to the related commercial products and services built around KIR proteins, KIR genes, ligand recognition, and functional immune analysis. They are not visible stand-alone devices, but molecular receptors located on the cell membrane, typically composed of extracellular immunoglobulin-like domains, a transmembrane region, and a cytoplasmic tail. Structurally, KIRs can contain two or three extracellular immunoglobulin-like domains, while functionally they include inhibitory and activating receptor types. Commercial products include genotyping kits, sequencing and testing services, flow cytometry antibodies, conjugated antibodies, recombinant proteins, plasmids, cell models, and reference antibodies for drug discovery. Their mechanism is based on recognizing human leukocyte antigen-related ligands and regulating natural killer cell cytotoxicity, immune tolerance, and immune surveillance. Major use scenarios include transplant immunogenetics, natural killer cell research, oncology immunology, immune phenotyping, therapeutic antibody discovery, cell therapy development, and reproductive immunology research.
Market growth opportunities are mainly supported by three demand streams. First, transplant immunogenetics and cell therapy are increasing the need to understand donor-recipient immune background, which supports demand for genotyping, receptor-ligand analysis, and immune risk assessment. Second, the rising importance of natural killer cells in oncology, infectious disease, and autoimmune research is expanding demand for flow cytometry antibodies, recombinant proteins, and functional validation materials. Third, more specific receptor targets are moving part of the market closer to translational development, especially in therapeutic antibody programs, immune monitoring, and potential companion testing workflows.
The main market challenges are clinical evidence, standardization, and commercial scale. These products are used mostly by specialized laboratories, transplant centers, academic institutes, and drug developers, so the customer base is much narrower than that of routine clinical diagnostics. Complex polymorphism, haplotype variation, gene copy number differences, and platform-specific interpretation create technical barriers in quality control and reporting. The value of routine KIR-based decision-making still requires stronger prospective evidence, so near-term market development should be assessed as steady professional adoption rather than mass-market expansion.
Downstream demand is expected to shift from single-product purchasing toward integrated solutions. Transplant-related users will increasingly combine genotyping, ligand matching, and long-term outcome data. Oncology immunology users will focus more on receptor expression, immune-cell functional status, and treatment response monitoring. Drug developers will require higher target specificity, antibody affinity validation, cytotoxicity mechanism studies, and clinical sample-based evidence. Faster-growing product categories are likely to include high-throughput typing, conjugated antibody panels, recombinant proteins, reference antibodies, and testing services designed for clinical research.
This report is a detailed and comprehensive analysis for global Killer-cell immunoglobulin-like receptors (KIRs) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Killer-cell immunoglobulin-like receptors (KIRs) market size and forecasts, in consumption value ($ Million), 2021-2032
Global Killer-cell immunoglobulin-like receptors (KIRs) market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Killer-cell immunoglobulin-like receptors (KIRs) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Killer-cell immunoglobulin-like receptors (KIRs) market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Killer-cell immunoglobulin-like receptors (KIRs)
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Killer-cell immunoglobulin-like receptors (KIRs) market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- KIR Genotyping Products and Services
- KIR/CD158 Antibodies and Flow Cytometry Reagents
- Recombinant KIR Proteins and Related Research Reagents
- 2D KIR Products
- 3D KIR Products
- Pan-KIR or Mixed KIR Panel Products
- Inhibitory KIR-related Products
- Activating KIR-related Products
- Mixed KIR Panel Products
- Medical Science
- Experiment
- Other
- Thermo Fisher Scientific
- Becton Dickinson
- Beckman Coulter Life Sciences
- Bio-Rad
- Revvity
- Bio-Techne
- Miltenyi Biotec
- Merck
- Abcam
- Werfen
- CareDx
- GenDx
- HistoGenetics
- DKMS Life Science Lab
- Scisco Genetics
- Labcorp
- GeneTex
- Proteintech
- Cell Signaling Technology
- OriGene
- MyBioSource
- Aviva Systems Biology
- NSJ Bioreagents
- Boster Bio
- KACTUS
- ProteoGenix
- Biorbyt
- Abbexa
- St John?s Laboratory
- Innate Pharma
- ACROBiosystems
- Sino Biological
- GenScript
- CUSABIO
- Solarbio
- WeHelp
- CapitalBio
- Genomeditech
- Abnova
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
- Chapter 1, to describe Killer-cell immunoglobulin-like receptors (KIRs) product scope, market overview, market estimation caveats and base year.
- Chapter 2, to profile the top players of Killer-cell immunoglobulin-like receptors (KIRs), with revenue, gross margin, and global market share of Killer-cell immunoglobulin-like receptors (KIRs) from 2021 to 2026.
- Chapter 3, the Killer-cell immunoglobulin-like receptors (KIRs) competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
- Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
- Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Killer-cell immunoglobulin-like receptors (KIRs) market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
- Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
- Chapter 12, the key raw materials and key suppliers, and industry chain of Killer-cell immunoglobulin-like receptors (KIRs).
- Chapter 13, to describe Killer-cell immunoglobulin-like receptors (KIRs) research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Killer-cell immunoglobulin-like receptors (KIRs) by Type
1.3.1 Overview: Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Type in 2025
1.3.3 KIR Genotyping Products and Services
1.3.4 KIR/CD158 Antibodies and Flow Cytometry Reagents
1.3.5 Recombinant KIR Proteins and Related Research Reagents
1.4 Classification of Killer-cell immunoglobulin-like receptors (KIRs) by Target Structure
1.4.1 Overview: Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Target Structure: 2021 Versus 2025 Versus 2032
1.4.2 Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Target Structure in 2025
1.4.3 2D KIR Products
1.4.4 3D KIR Products
1.4.5 Pan-KIR or Mixed KIR Panel Products
1.5 Classification of Killer-cell immunoglobulin-like receptors (KIRs) by Function
1.5.1 Overview: Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Function: 2021 Versus 2025 Versus 2032
1.5.2 Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Function in 2025
1.5.3 Inhibitory KIR-related Products
1.5.4 Activating KIR-related Products
1.5.5 Mixed KIR Panel Products
1.6 Global Killer-cell immunoglobulin-like receptors (KIRs) Market by Application
1.6.1 Overview: Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Medical Science
1.6.3 Experiment
1.6.4 Other
1.7 Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size & Forecast
1.8 Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast by Region
1.8.1 Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Region, (2021-2032)
1.8.3 North America Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Prospect (2021-2032)
1.8.4 Europe Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Prospect (2021-2032)
1.8.6 South America Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.1.4 Thermo Fisher Scientific Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 Becton Dickinson
2.2.1 Becton Dickinson Details
2.2.2 Becton Dickinson Major Business
2.2.3 Becton Dickinson Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.2.4 Becton Dickinson Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Becton Dickinson Recent Developments and Future Plans
2.3 Beckman Coulter Life Sciences
2.3.1 Beckman Coulter Life Sciences Details
2.3.2 Beckman Coulter Life Sciences Major Business
2.3.3 Beckman Coulter Life Sciences Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.3.4 Beckman Coulter Life Sciences Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Beckman Coulter Life Sciences Recent Developments and Future Plans
2.4 Bio-Rad
2.4.1 Bio-Rad Details
2.4.2 Bio-Rad Major Business
2.4.3 Bio-Rad Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.4.4 Bio-Rad Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Bio-Rad Recent Developments and Future Plans
2.5 Revvity
2.5.1 Revvity Details
2.5.2 Revvity Major Business
2.5.3 Revvity Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.5.4 Revvity Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Revvity Recent Developments and Future Plans
2.6 Bio-Techne
2.6.1 Bio-Techne Details
2.6.2 Bio-Techne Major Business
2.6.3 Bio-Techne Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.6.4 Bio-Techne Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Bio-Techne Recent Developments and Future Plans
2.7 Miltenyi Biotec
2.7.1 Miltenyi Biotec Details
2.7.2 Miltenyi Biotec Major Business
2.7.3 Miltenyi Biotec Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.7.4 Miltenyi Biotec Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Miltenyi Biotec Recent Developments and Future Plans
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business
2.8.3 Merck Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.8.4 Merck Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Merck Recent Developments and Future Plans
2.9 Abcam
2.9.1 Abcam Details
2.9.2 Abcam Major Business
2.9.3 Abcam Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.9.4 Abcam Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Abcam Recent Developments and Future Plans
2.10 Werfen
2.10.1 Werfen Details
2.10.2 Werfen Major Business
2.10.3 Werfen Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.10.4 Werfen Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Werfen Recent Developments and Future Plans
2.11 CareDx
2.11.1 CareDx Details
2.11.2 CareDx Major Business
2.11.3 CareDx Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.11.4 CareDx Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 CareDx Recent Developments and Future Plans
2.12 GenDx
2.12.1 GenDx Details
2.12.2 GenDx Major Business
2.12.3 GenDx Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.12.4 GenDx Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 GenDx Recent Developments and Future Plans
2.13 HistoGenetics
2.13.1 HistoGenetics Details
2.13.2 HistoGenetics Major Business
2.13.3 HistoGenetics Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.13.4 HistoGenetics Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 HistoGenetics Recent Developments and Future Plans
2.14 DKMS Life Science Lab
2.14.1 DKMS Life Science Lab Details
2.14.2 DKMS Life Science Lab Major Business
2.14.3 DKMS Life Science Lab Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.14.4 DKMS Life Science Lab Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 DKMS Life Science Lab Recent Developments and Future Plans
2.15 Scisco Genetics
2.15.1 Scisco Genetics Details
2.15.2 Scisco Genetics Major Business
2.15.3 Scisco Genetics Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.15.4 Scisco Genetics Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Scisco Genetics Recent Developments and Future Plans
2.16 Labcorp
2.16.1 Labcorp Details
2.16.2 Labcorp Major Business
2.16.3 Labcorp Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.16.4 Labcorp Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Labcorp Recent Developments and Future Plans
2.17 GeneTex
2.17.1 GeneTex Details
2.17.2 GeneTex Major Business
2.17.3 GeneTex Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.17.4 GeneTex Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 GeneTex Recent Developments and Future Plans
2.18 Proteintech
2.18.1 Proteintech Details
2.18.2 Proteintech Major Business
2.18.3 Proteintech Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.18.4 Proteintech Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Proteintech Recent Developments and Future Plans
2.19 Cell Signaling Technology
2.19.1 Cell Signaling Technology Details
2.19.2 Cell Signaling Technology Major Business
2.19.3 Cell Signaling Technology Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.19.4 Cell Signaling Technology Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Cell Signaling Technology Recent Developments and Future Plans
2.20 OriGene
2.20.1 OriGene Details
2.20.2 OriGene Major Business
2.20.3 OriGene Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.20.4 OriGene Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 OriGene Recent Developments and Future Plans
2.21 MyBioSource
2.21.1 MyBioSource Details
2.21.2 MyBioSource Major Business
2.21.3 MyBioSource Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.21.4 MyBioSource Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 MyBioSource Recent Developments and Future Plans
2.22 Aviva Systems Biology
2.22.1 Aviva Systems Biology Details
2.22.2 Aviva Systems Biology Major Business
2.22.3 Aviva Systems Biology Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.22.4 Aviva Systems Biology Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.22.5 Aviva Systems Biology Recent Developments and Future Plans
2.23 NSJ Bioreagents
2.23.1 NSJ Bioreagents Details
2.23.2 NSJ Bioreagents Major Business
2.23.3 NSJ Bioreagents Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.23.4 NSJ Bioreagents Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.23.5 NSJ Bioreagents Recent Developments and Future Plans
2.24 Boster Bio
2.24.1 Boster Bio Details
2.24.2 Boster Bio Major Business
2.24.3 Boster Bio Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.24.4 Boster Bio Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.24.5 Boster Bio Recent Developments and Future Plans
2.25 KACTUS
2.25.1 KACTUS Details
2.25.2 KACTUS Major Business
2.25.3 KACTUS Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.25.4 KACTUS Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.25.5 KACTUS Recent Developments and Future Plans
2.26 ProteoGenix
2.26.1 ProteoGenix Details
2.26.2 ProteoGenix Major Business
2.26.3 ProteoGenix Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.26.4 ProteoGenix Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.26.5 ProteoGenix Recent Developments and Future Plans
2.27 Biorbyt
2.27.1 Biorbyt Details
2.27.2 Biorbyt Major Business
2.27.3 Biorbyt Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.27.4 Biorbyt Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.27.5 Biorbyt Recent Developments and Future Plans
2.28 Abbexa
2.28.1 Abbexa Details
2.28.2 Abbexa Major Business
2.28.3 Abbexa Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.28.4 Abbexa Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.28.5 Abbexa Recent Developments and Future Plans
2.29 St John?s Laboratory
2.29.1 St John?s Laboratory Details
2.29.2 St John?s Laboratory Major Business
2.29.3 St John?s Laboratory Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.29.4 St John?s Laboratory Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.29.5 St John?s Laboratory Recent Developments and Future Plans
2.30 Innate Pharma
2.30.1 Innate Pharma Details
2.30.2 Innate Pharma Major Business
2.30.3 Innate Pharma Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.30.4 Innate Pharma Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.30.5 Innate Pharma Recent Developments and Future Plans
2.31 ACROBiosystems
2.31.1 ACROBiosystems Details
2.31.2 ACROBiosystems Major Business
2.31.3 ACROBiosystems Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.31.4 ACROBiosystems Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.31.5 ACROBiosystems Recent Developments and Future Plans
2.32 Sino Biological
2.32.1 Sino Biological Details
2.32.2 Sino Biological Major Business
2.32.3 Sino Biological Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.32.4 Sino Biological Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.32.5 Sino Biological Recent Developments and Future Plans
2.33 GenScript
2.33.1 GenScript Details
2.33.2 GenScript Major Business
2.33.3 GenScript Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.33.4 GenScript Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.33.5 GenScript Recent Developments and Future Plans
2.34 CUSABIO
2.34.1 CUSABIO Details
2.34.2 CUSABIO Major Business
2.34.3 CUSABIO Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.34.4 CUSABIO Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.34.5 CUSABIO Recent Developments and Future Plans
2.35 Solarbio
2.35.1 Solarbio Details
2.35.2 Solarbio Major Business
2.35.3 Solarbio Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.35.4 Solarbio Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.35.5 Solarbio Recent Developments and Future Plans
2.36 WeHelp
2.36.1 WeHelp Details
2.36.2 WeHelp Major Business
2.36.3 WeHelp Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.36.4 WeHelp Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.36.5 WeHelp Recent Developments and Future Plans
2.37 CapitalBio
2.37.1 CapitalBio Details
2.37.2 CapitalBio Major Business
2.37.3 CapitalBio Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.37.4 CapitalBio Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.37.5 CapitalBio Recent Developments and Future Plans
2.38 Genomeditech
2.38.1 Genomeditech Details
2.38.2 Genomeditech Major Business
2.38.3 Genomeditech Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.38.4 Genomeditech Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.38.5 Genomeditech Recent Developments and Future Plans
2.39 Abnova
2.39.1 Abnova Details
2.39.2 Abnova Major Business
2.39.3 Abnova Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.39.4 Abnova Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.39.5 Abnova Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Killer-cell immunoglobulin-like receptors (KIRs) Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Killer-cell immunoglobulin-like receptors (KIRs) by Company Revenue
3.2.2 Top 3 Killer-cell immunoglobulin-like receptors (KIRs) Players Market Share in 2025
3.2.3 Top 6 Killer-cell immunoglobulin-like receptors (KIRs) Players Market Share in 2025
3.3 Killer-cell immunoglobulin-like receptors (KIRs) Market: Overall Company Footprint Analysis
3.3.1 Killer-cell immunoglobulin-like receptors (KIRs) Market: Region Footprint
3.3.2 Killer-cell immunoglobulin-like receptors (KIRs) Market: Company Product Type Footprint
3.3.3 Killer-cell immunoglobulin-like receptors (KIRs) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value and Market Share by Type (2021-2026)
4.2 Global Killer-cell immunoglobulin-like receptors (KIRs) Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Application (2021-2026)
5.2 Global Killer-cell immunoglobulin-like receptors (KIRs) Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type (2021-2032)
6.2 North America Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application (2021-2032)
6.3 North America Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Country
6.3.1 North America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Country (2021-2032)
6.3.2 United States Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
6.3.3 Canada Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
6.3.4 Mexico Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type (2021-2032)
7.2 Europe Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application (2021-2032)
7.3 Europe Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Country
7.3.1 Europe Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Country (2021-2032)
7.3.2 Germany Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
7.3.3 France Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
7.3.5 Russia Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
7.3.6 Italy Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Region
8.3.1 Asia-Pacific Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Region (2021-2032)
8.3.2 China Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
8.3.3 Japan Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
8.3.4 South Korea Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
8.3.5 India Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
8.3.7 Australia Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type (2021-2032)
9.2 South America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application (2021-2032)
9.3 South America Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Country
9.3.1 South America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Country (2021-2032)
9.3.2 Brazil Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
9.3.3 Argentina Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Country
10.3.1 Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Country (2021-2032)
10.3.2 Turkey Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
10.3.4 UAE Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Killer-cell immunoglobulin-like receptors (KIRs) Market Drivers
11.2 Killer-cell immunoglobulin-like receptors (KIRs) Market Restraints
11.3 Killer-cell immunoglobulin-like receptors (KIRs) Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Killer-cell immunoglobulin-like receptors (KIRs) Industry Chain
12.2 Killer-cell immunoglobulin-like receptors (KIRs) Upstream Analysis
12.3 Killer-cell immunoglobulin-like receptors (KIRs) Midstream Analysis
12.4 Killer-cell immunoglobulin-like receptors (KIRs) Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Killer-cell immunoglobulin-like receptors (KIRs) by Type
1.3.1 Overview: Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Type in 2025
1.3.3 KIR Genotyping Products and Services
1.3.4 KIR/CD158 Antibodies and Flow Cytometry Reagents
1.3.5 Recombinant KIR Proteins and Related Research Reagents
1.4 Classification of Killer-cell immunoglobulin-like receptors (KIRs) by Target Structure
1.4.1 Overview: Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Target Structure: 2021 Versus 2025 Versus 2032
1.4.2 Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Target Structure in 2025
1.4.3 2D KIR Products
1.4.4 3D KIR Products
1.4.5 Pan-KIR or Mixed KIR Panel Products
1.5 Classification of Killer-cell immunoglobulin-like receptors (KIRs) by Function
1.5.1 Overview: Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Function: 2021 Versus 2025 Versus 2032
1.5.2 Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Function in 2025
1.5.3 Inhibitory KIR-related Products
1.5.4 Activating KIR-related Products
1.5.5 Mixed KIR Panel Products
1.6 Global Killer-cell immunoglobulin-like receptors (KIRs) Market by Application
1.6.1 Overview: Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Medical Science
1.6.3 Experiment
1.6.4 Other
1.7 Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size & Forecast
1.8 Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast by Region
1.8.1 Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Region, (2021-2032)
1.8.3 North America Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Prospect (2021-2032)
1.8.4 Europe Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Prospect (2021-2032)
1.8.6 South America Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.1.4 Thermo Fisher Scientific Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 Becton Dickinson
2.2.1 Becton Dickinson Details
2.2.2 Becton Dickinson Major Business
2.2.3 Becton Dickinson Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.2.4 Becton Dickinson Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Becton Dickinson Recent Developments and Future Plans
2.3 Beckman Coulter Life Sciences
2.3.1 Beckman Coulter Life Sciences Details
2.3.2 Beckman Coulter Life Sciences Major Business
2.3.3 Beckman Coulter Life Sciences Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.3.4 Beckman Coulter Life Sciences Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Beckman Coulter Life Sciences Recent Developments and Future Plans
2.4 Bio-Rad
2.4.1 Bio-Rad Details
2.4.2 Bio-Rad Major Business
2.4.3 Bio-Rad Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.4.4 Bio-Rad Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Bio-Rad Recent Developments and Future Plans
2.5 Revvity
2.5.1 Revvity Details
2.5.2 Revvity Major Business
2.5.3 Revvity Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.5.4 Revvity Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Revvity Recent Developments and Future Plans
2.6 Bio-Techne
2.6.1 Bio-Techne Details
2.6.2 Bio-Techne Major Business
2.6.3 Bio-Techne Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.6.4 Bio-Techne Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Bio-Techne Recent Developments and Future Plans
2.7 Miltenyi Biotec
2.7.1 Miltenyi Biotec Details
2.7.2 Miltenyi Biotec Major Business
2.7.3 Miltenyi Biotec Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.7.4 Miltenyi Biotec Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Miltenyi Biotec Recent Developments and Future Plans
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business
2.8.3 Merck Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.8.4 Merck Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Merck Recent Developments and Future Plans
2.9 Abcam
2.9.1 Abcam Details
2.9.2 Abcam Major Business
2.9.3 Abcam Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.9.4 Abcam Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Abcam Recent Developments and Future Plans
2.10 Werfen
2.10.1 Werfen Details
2.10.2 Werfen Major Business
2.10.3 Werfen Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.10.4 Werfen Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Werfen Recent Developments and Future Plans
2.11 CareDx
2.11.1 CareDx Details
2.11.2 CareDx Major Business
2.11.3 CareDx Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.11.4 CareDx Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 CareDx Recent Developments and Future Plans
2.12 GenDx
2.12.1 GenDx Details
2.12.2 GenDx Major Business
2.12.3 GenDx Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.12.4 GenDx Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 GenDx Recent Developments and Future Plans
2.13 HistoGenetics
2.13.1 HistoGenetics Details
2.13.2 HistoGenetics Major Business
2.13.3 HistoGenetics Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.13.4 HistoGenetics Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 HistoGenetics Recent Developments and Future Plans
2.14 DKMS Life Science Lab
2.14.1 DKMS Life Science Lab Details
2.14.2 DKMS Life Science Lab Major Business
2.14.3 DKMS Life Science Lab Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.14.4 DKMS Life Science Lab Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 DKMS Life Science Lab Recent Developments and Future Plans
2.15 Scisco Genetics
2.15.1 Scisco Genetics Details
2.15.2 Scisco Genetics Major Business
2.15.3 Scisco Genetics Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.15.4 Scisco Genetics Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Scisco Genetics Recent Developments and Future Plans
2.16 Labcorp
2.16.1 Labcorp Details
2.16.2 Labcorp Major Business
2.16.3 Labcorp Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.16.4 Labcorp Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Labcorp Recent Developments and Future Plans
2.17 GeneTex
2.17.1 GeneTex Details
2.17.2 GeneTex Major Business
2.17.3 GeneTex Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.17.4 GeneTex Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 GeneTex Recent Developments and Future Plans
2.18 Proteintech
2.18.1 Proteintech Details
2.18.2 Proteintech Major Business
2.18.3 Proteintech Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.18.4 Proteintech Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Proteintech Recent Developments and Future Plans
2.19 Cell Signaling Technology
2.19.1 Cell Signaling Technology Details
2.19.2 Cell Signaling Technology Major Business
2.19.3 Cell Signaling Technology Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.19.4 Cell Signaling Technology Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Cell Signaling Technology Recent Developments and Future Plans
2.20 OriGene
2.20.1 OriGene Details
2.20.2 OriGene Major Business
2.20.3 OriGene Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.20.4 OriGene Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 OriGene Recent Developments and Future Plans
2.21 MyBioSource
2.21.1 MyBioSource Details
2.21.2 MyBioSource Major Business
2.21.3 MyBioSource Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.21.4 MyBioSource Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 MyBioSource Recent Developments and Future Plans
2.22 Aviva Systems Biology
2.22.1 Aviva Systems Biology Details
2.22.2 Aviva Systems Biology Major Business
2.22.3 Aviva Systems Biology Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.22.4 Aviva Systems Biology Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.22.5 Aviva Systems Biology Recent Developments and Future Plans
2.23 NSJ Bioreagents
2.23.1 NSJ Bioreagents Details
2.23.2 NSJ Bioreagents Major Business
2.23.3 NSJ Bioreagents Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.23.4 NSJ Bioreagents Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.23.5 NSJ Bioreagents Recent Developments and Future Plans
2.24 Boster Bio
2.24.1 Boster Bio Details
2.24.2 Boster Bio Major Business
2.24.3 Boster Bio Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.24.4 Boster Bio Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.24.5 Boster Bio Recent Developments and Future Plans
2.25 KACTUS
2.25.1 KACTUS Details
2.25.2 KACTUS Major Business
2.25.3 KACTUS Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.25.4 KACTUS Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.25.5 KACTUS Recent Developments and Future Plans
2.26 ProteoGenix
2.26.1 ProteoGenix Details
2.26.2 ProteoGenix Major Business
2.26.3 ProteoGenix Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.26.4 ProteoGenix Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.26.5 ProteoGenix Recent Developments and Future Plans
2.27 Biorbyt
2.27.1 Biorbyt Details
2.27.2 Biorbyt Major Business
2.27.3 Biorbyt Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.27.4 Biorbyt Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.27.5 Biorbyt Recent Developments and Future Plans
2.28 Abbexa
2.28.1 Abbexa Details
2.28.2 Abbexa Major Business
2.28.3 Abbexa Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.28.4 Abbexa Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.28.5 Abbexa Recent Developments and Future Plans
2.29 St John?s Laboratory
2.29.1 St John?s Laboratory Details
2.29.2 St John?s Laboratory Major Business
2.29.3 St John?s Laboratory Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.29.4 St John?s Laboratory Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.29.5 St John?s Laboratory Recent Developments and Future Plans
2.30 Innate Pharma
2.30.1 Innate Pharma Details
2.30.2 Innate Pharma Major Business
2.30.3 Innate Pharma Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.30.4 Innate Pharma Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.30.5 Innate Pharma Recent Developments and Future Plans
2.31 ACROBiosystems
2.31.1 ACROBiosystems Details
2.31.2 ACROBiosystems Major Business
2.31.3 ACROBiosystems Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.31.4 ACROBiosystems Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.31.5 ACROBiosystems Recent Developments and Future Plans
2.32 Sino Biological
2.32.1 Sino Biological Details
2.32.2 Sino Biological Major Business
2.32.3 Sino Biological Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.32.4 Sino Biological Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.32.5 Sino Biological Recent Developments and Future Plans
2.33 GenScript
2.33.1 GenScript Details
2.33.2 GenScript Major Business
2.33.3 GenScript Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.33.4 GenScript Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.33.5 GenScript Recent Developments and Future Plans
2.34 CUSABIO
2.34.1 CUSABIO Details
2.34.2 CUSABIO Major Business
2.34.3 CUSABIO Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.34.4 CUSABIO Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.34.5 CUSABIO Recent Developments and Future Plans
2.35 Solarbio
2.35.1 Solarbio Details
2.35.2 Solarbio Major Business
2.35.3 Solarbio Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.35.4 Solarbio Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.35.5 Solarbio Recent Developments and Future Plans
2.36 WeHelp
2.36.1 WeHelp Details
2.36.2 WeHelp Major Business
2.36.3 WeHelp Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.36.4 WeHelp Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.36.5 WeHelp Recent Developments and Future Plans
2.37 CapitalBio
2.37.1 CapitalBio Details
2.37.2 CapitalBio Major Business
2.37.3 CapitalBio Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.37.4 CapitalBio Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.37.5 CapitalBio Recent Developments and Future Plans
2.38 Genomeditech
2.38.1 Genomeditech Details
2.38.2 Genomeditech Major Business
2.38.3 Genomeditech Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.38.4 Genomeditech Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.38.5 Genomeditech Recent Developments and Future Plans
2.39 Abnova
2.39.1 Abnova Details
2.39.2 Abnova Major Business
2.39.3 Abnova Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
2.39.4 Abnova Killer-cell immunoglobulin-like receptors (KIRs) Revenue, Gross Margin and Market Share (2021-2026)
2.39.5 Abnova Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Killer-cell immunoglobulin-like receptors (KIRs) Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Killer-cell immunoglobulin-like receptors (KIRs) by Company Revenue
3.2.2 Top 3 Killer-cell immunoglobulin-like receptors (KIRs) Players Market Share in 2025
3.2.3 Top 6 Killer-cell immunoglobulin-like receptors (KIRs) Players Market Share in 2025
3.3 Killer-cell immunoglobulin-like receptors (KIRs) Market: Overall Company Footprint Analysis
3.3.1 Killer-cell immunoglobulin-like receptors (KIRs) Market: Region Footprint
3.3.2 Killer-cell immunoglobulin-like receptors (KIRs) Market: Company Product Type Footprint
3.3.3 Killer-cell immunoglobulin-like receptors (KIRs) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value and Market Share by Type (2021-2026)
4.2 Global Killer-cell immunoglobulin-like receptors (KIRs) Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Application (2021-2026)
5.2 Global Killer-cell immunoglobulin-like receptors (KIRs) Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type (2021-2032)
6.2 North America Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Application (2021-2032)
6.3 North America Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Country
6.3.1 North America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Country (2021-2032)
6.3.2 United States Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
6.3.3 Canada Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
6.3.4 Mexico Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type (2021-2032)
7.2 Europe Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application (2021-2032)
7.3 Europe Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Country
7.3.1 Europe Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Country (2021-2032)
7.3.2 Germany Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
7.3.3 France Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
7.3.5 Russia Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
7.3.6 Italy Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Region
8.3.1 Asia-Pacific Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Region (2021-2032)
8.3.2 China Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
8.3.3 Japan Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
8.3.4 South Korea Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
8.3.5 India Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
8.3.7 Australia Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type (2021-2032)
9.2 South America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application (2021-2032)
9.3 South America Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Country
9.3.1 South America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Country (2021-2032)
9.3.2 Brazil Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
9.3.3 Argentina Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Market Size by Country
10.3.1 Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Country (2021-2032)
10.3.2 Turkey Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
10.3.4 UAE Killer-cell immunoglobulin-like receptors (KIRs) Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Killer-cell immunoglobulin-like receptors (KIRs) Market Drivers
11.2 Killer-cell immunoglobulin-like receptors (KIRs) Market Restraints
11.3 Killer-cell immunoglobulin-like receptors (KIRs) Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Killer-cell immunoglobulin-like receptors (KIRs) Industry Chain
12.2 Killer-cell immunoglobulin-like receptors (KIRs) Upstream Analysis
12.3 Killer-cell immunoglobulin-like receptors (KIRs) Midstream Analysis
12.4 Killer-cell immunoglobulin-like receptors (KIRs) Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Target Structure, (USD Million), 2021 & 2025 & 2032
Table 3. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Function, (USD Million), 2021 & 2025 & 2032
Table 4. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 8. Thermo Fisher Scientific Major Business
Table 9. Thermo Fisher Scientific Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 10. Thermo Fisher Scientific Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Thermo Fisher Scientific Recent Developments and Future Plans
Table 12. Becton Dickinson Company Information, Head Office, and Major Competitors
Table 13. Becton Dickinson Major Business
Table 14. Becton Dickinson Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 15. Becton Dickinson Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Becton Dickinson Recent Developments and Future Plans
Table 17. Beckman Coulter Life Sciences Company Information, Head Office, and Major Competitors
Table 18. Beckman Coulter Life Sciences Major Business
Table 19. Beckman Coulter Life Sciences Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 20. Beckman Coulter Life Sciences Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Bio-Rad Company Information, Head Office, and Major Competitors
Table 22. Bio-Rad Major Business
Table 23. Bio-Rad Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 24. Bio-Rad Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Bio-Rad Recent Developments and Future Plans
Table 26. Revvity Company Information, Head Office, and Major Competitors
Table 27. Revvity Major Business
Table 28. Revvity Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 29. Revvity Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Revvity Recent Developments and Future Plans
Table 31. Bio-Techne Company Information, Head Office, and Major Competitors
Table 32. Bio-Techne Major Business
Table 33. Bio-Techne Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 34. Bio-Techne Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Bio-Techne Recent Developments and Future Plans
Table 36. Miltenyi Biotec Company Information, Head Office, and Major Competitors
Table 37. Miltenyi Biotec Major Business
Table 38. Miltenyi Biotec Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 39. Miltenyi Biotec Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Miltenyi Biotec Recent Developments and Future Plans
Table 41. Merck Company Information, Head Office, and Major Competitors
Table 42. Merck Major Business
Table 43. Merck Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 44. Merck Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Merck Recent Developments and Future Plans
Table 46. Abcam Company Information, Head Office, and Major Competitors
Table 47. Abcam Major Business
Table 48. Abcam Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 49. Abcam Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Abcam Recent Developments and Future Plans
Table 51. Werfen Company Information, Head Office, and Major Competitors
Table 52. Werfen Major Business
Table 53. Werfen Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 54. Werfen Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Werfen Recent Developments and Future Plans
Table 56. CareDx Company Information, Head Office, and Major Competitors
Table 57. CareDx Major Business
Table 58. CareDx Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 59. CareDx Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. CareDx Recent Developments and Future Plans
Table 61. GenDx Company Information, Head Office, and Major Competitors
Table 62. GenDx Major Business
Table 63. GenDx Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 64. GenDx Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. GenDx Recent Developments and Future Plans
Table 66. HistoGenetics Company Information, Head Office, and Major Competitors
Table 67. HistoGenetics Major Business
Table 68. HistoGenetics Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 69. HistoGenetics Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. HistoGenetics Recent Developments and Future Plans
Table 71. DKMS Life Science Lab Company Information, Head Office, and Major Competitors
Table 72. DKMS Life Science Lab Major Business
Table 73. DKMS Life Science Lab Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 74. DKMS Life Science Lab Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. DKMS Life Science Lab Recent Developments and Future Plans
Table 76. Scisco Genetics Company Information, Head Office, and Major Competitors
Table 77. Scisco Genetics Major Business
Table 78. Scisco Genetics Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 79. Scisco Genetics Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. Scisco Genetics Recent Developments and Future Plans
Table 81. Labcorp Company Information, Head Office, and Major Competitors
Table 82. Labcorp Major Business
Table 83. Labcorp Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 84. Labcorp Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Labcorp Recent Developments and Future Plans
Table 86. GeneTex Company Information, Head Office, and Major Competitors
Table 87. GeneTex Major Business
Table 88. GeneTex Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 89. GeneTex Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. GeneTex Recent Developments and Future Plans
Table 91. Proteintech Company Information, Head Office, and Major Competitors
Table 92. Proteintech Major Business
Table 93. Proteintech Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 94. Proteintech Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Proteintech Recent Developments and Future Plans
Table 96. Cell Signaling Technology Company Information, Head Office, and Major Competitors
Table 97. Cell Signaling Technology Major Business
Table 98. Cell Signaling Technology Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 99. Cell Signaling Technology Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 100. Cell Signaling Technology Recent Developments and Future Plans
Table 101. OriGene Company Information, Head Office, and Major Competitors
Table 102. OriGene Major Business
Table 103. OriGene Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 104. OriGene Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 105. OriGene Recent Developments and Future Plans
Table 106. MyBioSource Company Information, Head Office, and Major Competitors
Table 107. MyBioSource Major Business
Table 108. MyBioSource Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 109. MyBioSource Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. MyBioSource Recent Developments and Future Plans
Table 111. Aviva Systems Biology Company Information, Head Office, and Major Competitors
Table 112. Aviva Systems Biology Major Business
Table 113. Aviva Systems Biology Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 114. Aviva Systems Biology Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Aviva Systems Biology Recent Developments and Future Plans
Table 116. NSJ Bioreagents Company Information, Head Office, and Major Competitors
Table 117. NSJ Bioreagents Major Business
Table 118. NSJ Bioreagents Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 119. NSJ Bioreagents Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. NSJ Bioreagents Recent Developments and Future Plans
Table 121. Boster Bio Company Information, Head Office, and Major Competitors
Table 122. Boster Bio Major Business
Table 123. Boster Bio Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 124. Boster Bio Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. Boster Bio Recent Developments and Future Plans
Table 126. KACTUS Company Information, Head Office, and Major Competitors
Table 127. KACTUS Major Business
Table 128. KACTUS Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 129. KACTUS Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 130. KACTUS Recent Developments and Future Plans
Table 131. ProteoGenix Company Information, Head Office, and Major Competitors
Table 132. ProteoGenix Major Business
Table 133. ProteoGenix Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 134. ProteoGenix Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 135. ProteoGenix Recent Developments and Future Plans
Table 136. Biorbyt Company Information, Head Office, and Major Competitors
Table 137. Biorbyt Major Business
Table 138. Biorbyt Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 139. Biorbyt Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 140. Biorbyt Recent Developments and Future Plans
Table 141. Abbexa Company Information, Head Office, and Major Competitors
Table 142. Abbexa Major Business
Table 143. Abbexa Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 144. Abbexa Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Abbexa Recent Developments and Future Plans
Table 146. St John?s Laboratory Company Information, Head Office, and Major Competitors
Table 147. St John?s Laboratory Major Business
Table 148. St John?s Laboratory Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 149. St John?s Laboratory Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 150. St John?s Laboratory Recent Developments and Future Plans
Table 151. Innate Pharma Company Information, Head Office, and Major Competitors
Table 152. Innate Pharma Major Business
Table 153. Innate Pharma Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 154. Innate Pharma Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 155. Innate Pharma Recent Developments and Future Plans
Table 156. ACROBiosystems Company Information, Head Office, and Major Competitors
Table 157. ACROBiosystems Major Business
Table 158. ACROBiosystems Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 159. ACROBiosystems Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 160. ACROBiosystems Recent Developments and Future Plans
Table 161. Sino Biological Company Information, Head Office, and Major Competitors
Table 162. Sino Biological Major Business
Table 163. Sino Biological Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 164. Sino Biological Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 165. Sino Biological Recent Developments and Future Plans
Table 166. GenScript Company Information, Head Office, and Major Competitors
Table 167. GenScript Major Business
Table 168. GenScript Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 169. GenScript Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 170. GenScript Recent Developments and Future Plans
Table 171. CUSABIO Company Information, Head Office, and Major Competitors
Table 172. CUSABIO Major Business
Table 173. CUSABIO Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 174. CUSABIO Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. CUSABIO Recent Developments and Future Plans
Table 176. Solarbio Company Information, Head Office, and Major Competitors
Table 177. Solarbio Major Business
Table 178. Solarbio Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 179. Solarbio Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 180. Solarbio Recent Developments and Future Plans
Table 181. WeHelp Company Information, Head Office, and Major Competitors
Table 182. WeHelp Major Business
Table 183. WeHelp Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 184. WeHelp Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 185. WeHelp Recent Developments and Future Plans
Table 186. CapitalBio Company Information, Head Office, and Major Competitors
Table 187. CapitalBio Major Business
Table 188. CapitalBio Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 189. CapitalBio Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 190. CapitalBio Recent Developments and Future Plans
Table 191. Genomeditech Company Information, Head Office, and Major Competitors
Table 192. Genomeditech Major Business
Table 193. Genomeditech Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 194. Genomeditech Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 195. Genomeditech Recent Developments and Future Plans
Table 196. Abnova Company Information, Head Office, and Major Competitors
Table 197. Abnova Major Business
Table 198. Abnova Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 199. Abnova Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 200. Abnova Recent Developments and Future Plans
Table 201. Global Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million) by Players (2021-2026)
Table 202. Global Killer-cell immunoglobulin-like receptors (KIRs) Revenue Share by Players (2021-2026)
Table 203. Breakdown of Killer-cell immunoglobulin-like receptors (KIRs) by Company Type (Tier 1, Tier 2, and Tier 3)
Table 204. Market Position of Players in Killer-cell immunoglobulin-like receptors (KIRs), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 205. Head Office of Key Killer-cell immunoglobulin-like receptors (KIRs) Players
Table 206. Killer-cell immunoglobulin-like receptors (KIRs) Market: Company Product Type Footprint
Table 207. Killer-cell immunoglobulin-like receptors (KIRs) Market: Company Product Application Footprint
Table 208. Killer-cell immunoglobulin-like receptors (KIRs) New Market Entrants and Barriers to Market Entry
Table 209. Killer-cell immunoglobulin-like receptors (KIRs) Mergers, Acquisition, Agreements, and Collaborations
Table 210. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (USD Million) by Type (2021-2026)
Table 211. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Share by Type (2021-2026)
Table 212. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Forecast by Type (2027-2032)
Table 213. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application (2021-2026)
Table 214. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Forecast by Application (2027-2032)
Table 215. North America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type (2021-2026) & (USD Million)
Table 216. North America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type (2027-2032) & (USD Million)
Table 217. North America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application (2021-2026) & (USD Million)
Table 218. North America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application (2027-2032) & (USD Million)
Table 219. North America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Country (2021-2026) & (USD Million)
Table 220. North America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Country (2027-2032) & (USD Million)
Table 221. Europe Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type (2021-2026) & (USD Million)
Table 222. Europe Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type (2027-2032) & (USD Million)
Table 223. Europe Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application (2021-2026) & (USD Million)
Table 224. Europe Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application (2027-2032) & (USD Million)
Table 225. Europe Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Country (2021-2026) & (USD Million)
Table 226. Europe Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Country (2027-2032) & (USD Million)
Table 227. Asia-Pacific Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type (2021-2026) & (USD Million)
Table 228. Asia-Pacific Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type (2027-2032) & (USD Million)
Table 229. Asia-Pacific Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application (2021-2026) & (USD Million)
Table 230. Asia-Pacific Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application (2027-2032) & (USD Million)
Table 231. Asia-Pacific Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Region (2021-2026) & (USD Million)
Table 232. Asia-Pacific Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Region (2027-2032) & (USD Million)
Table 233. South America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type (2021-2026) & (USD Million)
Table 234. South America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type (2027-2032) & (USD Million)
Table 235. South America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application (2021-2026) & (USD Million)
Table 236. South America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application (2027-2032) & (USD Million)
Table 237. South America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Country (2021-2026) & (USD Million)
Table 238. South America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Country (2027-2032) & (USD Million)
Table 239. Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type (2021-2026) & (USD Million)
Table 240. Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type (2027-2032) & (USD Million)
Table 241. Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application (2021-2026) & (USD Million)
Table 242. Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application (2027-2032) & (USD Million)
Table 243. Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Country (2021-2026) & (USD Million)
Table 244. Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Country (2027-2032) & (USD Million)
Table 245. Global Key Players of Killer-cell immunoglobulin-like receptors (KIRs) Upstream (Raw Materials)
Table 246. Global Killer-cell immunoglobulin-like receptors (KIRs) Typical Customers
Table 1. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Target Structure, (USD Million), 2021 & 2025 & 2032
Table 3. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Function, (USD Million), 2021 & 2025 & 2032
Table 4. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 8. Thermo Fisher Scientific Major Business
Table 9. Thermo Fisher Scientific Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 10. Thermo Fisher Scientific Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Thermo Fisher Scientific Recent Developments and Future Plans
Table 12. Becton Dickinson Company Information, Head Office, and Major Competitors
Table 13. Becton Dickinson Major Business
Table 14. Becton Dickinson Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 15. Becton Dickinson Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Becton Dickinson Recent Developments and Future Plans
Table 17. Beckman Coulter Life Sciences Company Information, Head Office, and Major Competitors
Table 18. Beckman Coulter Life Sciences Major Business
Table 19. Beckman Coulter Life Sciences Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 20. Beckman Coulter Life Sciences Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Bio-Rad Company Information, Head Office, and Major Competitors
Table 22. Bio-Rad Major Business
Table 23. Bio-Rad Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 24. Bio-Rad Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Bio-Rad Recent Developments and Future Plans
Table 26. Revvity Company Information, Head Office, and Major Competitors
Table 27. Revvity Major Business
Table 28. Revvity Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 29. Revvity Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Revvity Recent Developments and Future Plans
Table 31. Bio-Techne Company Information, Head Office, and Major Competitors
Table 32. Bio-Techne Major Business
Table 33. Bio-Techne Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 34. Bio-Techne Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Bio-Techne Recent Developments and Future Plans
Table 36. Miltenyi Biotec Company Information, Head Office, and Major Competitors
Table 37. Miltenyi Biotec Major Business
Table 38. Miltenyi Biotec Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 39. Miltenyi Biotec Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Miltenyi Biotec Recent Developments and Future Plans
Table 41. Merck Company Information, Head Office, and Major Competitors
Table 42. Merck Major Business
Table 43. Merck Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 44. Merck Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Merck Recent Developments and Future Plans
Table 46. Abcam Company Information, Head Office, and Major Competitors
Table 47. Abcam Major Business
Table 48. Abcam Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 49. Abcam Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Abcam Recent Developments and Future Plans
Table 51. Werfen Company Information, Head Office, and Major Competitors
Table 52. Werfen Major Business
Table 53. Werfen Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 54. Werfen Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Werfen Recent Developments and Future Plans
Table 56. CareDx Company Information, Head Office, and Major Competitors
Table 57. CareDx Major Business
Table 58. CareDx Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 59. CareDx Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. CareDx Recent Developments and Future Plans
Table 61. GenDx Company Information, Head Office, and Major Competitors
Table 62. GenDx Major Business
Table 63. GenDx Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 64. GenDx Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. GenDx Recent Developments and Future Plans
Table 66. HistoGenetics Company Information, Head Office, and Major Competitors
Table 67. HistoGenetics Major Business
Table 68. HistoGenetics Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 69. HistoGenetics Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. HistoGenetics Recent Developments and Future Plans
Table 71. DKMS Life Science Lab Company Information, Head Office, and Major Competitors
Table 72. DKMS Life Science Lab Major Business
Table 73. DKMS Life Science Lab Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 74. DKMS Life Science Lab Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. DKMS Life Science Lab Recent Developments and Future Plans
Table 76. Scisco Genetics Company Information, Head Office, and Major Competitors
Table 77. Scisco Genetics Major Business
Table 78. Scisco Genetics Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 79. Scisco Genetics Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. Scisco Genetics Recent Developments and Future Plans
Table 81. Labcorp Company Information, Head Office, and Major Competitors
Table 82. Labcorp Major Business
Table 83. Labcorp Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 84. Labcorp Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Labcorp Recent Developments and Future Plans
Table 86. GeneTex Company Information, Head Office, and Major Competitors
Table 87. GeneTex Major Business
Table 88. GeneTex Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 89. GeneTex Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. GeneTex Recent Developments and Future Plans
Table 91. Proteintech Company Information, Head Office, and Major Competitors
Table 92. Proteintech Major Business
Table 93. Proteintech Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 94. Proteintech Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Proteintech Recent Developments and Future Plans
Table 96. Cell Signaling Technology Company Information, Head Office, and Major Competitors
Table 97. Cell Signaling Technology Major Business
Table 98. Cell Signaling Technology Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 99. Cell Signaling Technology Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 100. Cell Signaling Technology Recent Developments and Future Plans
Table 101. OriGene Company Information, Head Office, and Major Competitors
Table 102. OriGene Major Business
Table 103. OriGene Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 104. OriGene Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 105. OriGene Recent Developments and Future Plans
Table 106. MyBioSource Company Information, Head Office, and Major Competitors
Table 107. MyBioSource Major Business
Table 108. MyBioSource Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 109. MyBioSource Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. MyBioSource Recent Developments and Future Plans
Table 111. Aviva Systems Biology Company Information, Head Office, and Major Competitors
Table 112. Aviva Systems Biology Major Business
Table 113. Aviva Systems Biology Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 114. Aviva Systems Biology Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Aviva Systems Biology Recent Developments and Future Plans
Table 116. NSJ Bioreagents Company Information, Head Office, and Major Competitors
Table 117. NSJ Bioreagents Major Business
Table 118. NSJ Bioreagents Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 119. NSJ Bioreagents Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. NSJ Bioreagents Recent Developments and Future Plans
Table 121. Boster Bio Company Information, Head Office, and Major Competitors
Table 122. Boster Bio Major Business
Table 123. Boster Bio Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 124. Boster Bio Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. Boster Bio Recent Developments and Future Plans
Table 126. KACTUS Company Information, Head Office, and Major Competitors
Table 127. KACTUS Major Business
Table 128. KACTUS Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 129. KACTUS Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 130. KACTUS Recent Developments and Future Plans
Table 131. ProteoGenix Company Information, Head Office, and Major Competitors
Table 132. ProteoGenix Major Business
Table 133. ProteoGenix Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 134. ProteoGenix Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 135. ProteoGenix Recent Developments and Future Plans
Table 136. Biorbyt Company Information, Head Office, and Major Competitors
Table 137. Biorbyt Major Business
Table 138. Biorbyt Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 139. Biorbyt Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 140. Biorbyt Recent Developments and Future Plans
Table 141. Abbexa Company Information, Head Office, and Major Competitors
Table 142. Abbexa Major Business
Table 143. Abbexa Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 144. Abbexa Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Abbexa Recent Developments and Future Plans
Table 146. St John?s Laboratory Company Information, Head Office, and Major Competitors
Table 147. St John?s Laboratory Major Business
Table 148. St John?s Laboratory Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 149. St John?s Laboratory Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 150. St John?s Laboratory Recent Developments and Future Plans
Table 151. Innate Pharma Company Information, Head Office, and Major Competitors
Table 152. Innate Pharma Major Business
Table 153. Innate Pharma Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 154. Innate Pharma Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 155. Innate Pharma Recent Developments and Future Plans
Table 156. ACROBiosystems Company Information, Head Office, and Major Competitors
Table 157. ACROBiosystems Major Business
Table 158. ACROBiosystems Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 159. ACROBiosystems Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 160. ACROBiosystems Recent Developments and Future Plans
Table 161. Sino Biological Company Information, Head Office, and Major Competitors
Table 162. Sino Biological Major Business
Table 163. Sino Biological Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 164. Sino Biological Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 165. Sino Biological Recent Developments and Future Plans
Table 166. GenScript Company Information, Head Office, and Major Competitors
Table 167. GenScript Major Business
Table 168. GenScript Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 169. GenScript Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 170. GenScript Recent Developments and Future Plans
Table 171. CUSABIO Company Information, Head Office, and Major Competitors
Table 172. CUSABIO Major Business
Table 173. CUSABIO Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 174. CUSABIO Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. CUSABIO Recent Developments and Future Plans
Table 176. Solarbio Company Information, Head Office, and Major Competitors
Table 177. Solarbio Major Business
Table 178. Solarbio Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 179. Solarbio Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 180. Solarbio Recent Developments and Future Plans
Table 181. WeHelp Company Information, Head Office, and Major Competitors
Table 182. WeHelp Major Business
Table 183. WeHelp Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 184. WeHelp Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 185. WeHelp Recent Developments and Future Plans
Table 186. CapitalBio Company Information, Head Office, and Major Competitors
Table 187. CapitalBio Major Business
Table 188. CapitalBio Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 189. CapitalBio Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 190. CapitalBio Recent Developments and Future Plans
Table 191. Genomeditech Company Information, Head Office, and Major Competitors
Table 192. Genomeditech Major Business
Table 193. Genomeditech Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 194. Genomeditech Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 195. Genomeditech Recent Developments and Future Plans
Table 196. Abnova Company Information, Head Office, and Major Competitors
Table 197. Abnova Major Business
Table 198. Abnova Killer-cell immunoglobulin-like receptors (KIRs) Product and Solutions
Table 199. Abnova Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 200. Abnova Recent Developments and Future Plans
Table 201. Global Killer-cell immunoglobulin-like receptors (KIRs) Revenue (USD Million) by Players (2021-2026)
Table 202. Global Killer-cell immunoglobulin-like receptors (KIRs) Revenue Share by Players (2021-2026)
Table 203. Breakdown of Killer-cell immunoglobulin-like receptors (KIRs) by Company Type (Tier 1, Tier 2, and Tier 3)
Table 204. Market Position of Players in Killer-cell immunoglobulin-like receptors (KIRs), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 205. Head Office of Key Killer-cell immunoglobulin-like receptors (KIRs) Players
Table 206. Killer-cell immunoglobulin-like receptors (KIRs) Market: Company Product Type Footprint
Table 207. Killer-cell immunoglobulin-like receptors (KIRs) Market: Company Product Application Footprint
Table 208. Killer-cell immunoglobulin-like receptors (KIRs) New Market Entrants and Barriers to Market Entry
Table 209. Killer-cell immunoglobulin-like receptors (KIRs) Mergers, Acquisition, Agreements, and Collaborations
Table 210. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (USD Million) by Type (2021-2026)
Table 211. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Share by Type (2021-2026)
Table 212. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Forecast by Type (2027-2032)
Table 213. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application (2021-2026)
Table 214. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Forecast by Application (2027-2032)
Table 215. North America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type (2021-2026) & (USD Million)
Table 216. North America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type (2027-2032) & (USD Million)
Table 217. North America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application (2021-2026) & (USD Million)
Table 218. North America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application (2027-2032) & (USD Million)
Table 219. North America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Country (2021-2026) & (USD Million)
Table 220. North America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Country (2027-2032) & (USD Million)
Table 221. Europe Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type (2021-2026) & (USD Million)
Table 222. Europe Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type (2027-2032) & (USD Million)
Table 223. Europe Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application (2021-2026) & (USD Million)
Table 224. Europe Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application (2027-2032) & (USD Million)
Table 225. Europe Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Country (2021-2026) & (USD Million)
Table 226. Europe Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Country (2027-2032) & (USD Million)
Table 227. Asia-Pacific Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type (2021-2026) & (USD Million)
Table 228. Asia-Pacific Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type (2027-2032) & (USD Million)
Table 229. Asia-Pacific Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application (2021-2026) & (USD Million)
Table 230. Asia-Pacific Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application (2027-2032) & (USD Million)
Table 231. Asia-Pacific Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Region (2021-2026) & (USD Million)
Table 232. Asia-Pacific Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Region (2027-2032) & (USD Million)
Table 233. South America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type (2021-2026) & (USD Million)
Table 234. South America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type (2027-2032) & (USD Million)
Table 235. South America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application (2021-2026) & (USD Million)
Table 236. South America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application (2027-2032) & (USD Million)
Table 237. South America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Country (2021-2026) & (USD Million)
Table 238. South America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Country (2027-2032) & (USD Million)
Table 239. Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type (2021-2026) & (USD Million)
Table 240. Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type (2027-2032) & (USD Million)
Table 241. Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application (2021-2026) & (USD Million)
Table 242. Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application (2027-2032) & (USD Million)
Table 243. Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Country (2021-2026) & (USD Million)
Table 244. Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Country (2027-2032) & (USD Million)
Table 245. Global Key Players of Killer-cell immunoglobulin-like receptors (KIRs) Upstream (Raw Materials)
Table 246. Global Killer-cell immunoglobulin-like receptors (KIRs) Typical Customers
LIST OF FIGURES
Figure 1. Killer-cell immunoglobulin-like receptors (KIRs) Picture
Figure 2. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Type in 2025
Figure 4. KIR Genotyping Products and Services
Figure 5. KIR/CD158 Antibodies and Flow Cytometry Reagents
Figure 6. Recombinant KIR Proteins and Related Research Reagents
Figure 7. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Target Structure, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Target Structure in 2025
Figure 9. 2D KIR Products
Figure 10. 3D KIR Products
Figure 11. Pan-KIR or Mixed KIR Panel Products
Figure 12. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Function, (USD Million), 2021 & 2025 & 2032
Figure 13. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Function in 2025
Figure 14. Inhibitory KIR-related Products
Figure 15. Activating KIR-related Products
Figure 16. Mixed KIR Panel Products
Figure 17. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 18. Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Application in 2025
Figure 19. Medical Science Picture
Figure 20. Experiment Picture
Figure 21. Other Picture
Figure 22. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 23. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 24. Global Market Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 25. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Region (2021-2032)
Figure 26. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Region in 2025
Figure 27. North America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 28. Europe Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 29. Asia-Pacific Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 30. South America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 31. Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 32. Company Three Recent Developments and Future Plans
Figure 33. Global Killer-cell immunoglobulin-like receptors (KIRs) Revenue Share by Players in 2025
Figure 34. Killer-cell immunoglobulin-like receptors (KIRs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 35. Market Share of Killer-cell immunoglobulin-like receptors (KIRs) by Player Revenue in 2025
Figure 36. Top 3 Killer-cell immunoglobulin-like receptors (KIRs) Players Market Share in 2025
Figure 37. Top 6 Killer-cell immunoglobulin-like receptors (KIRs) Players Market Share in 2025
Figure 38. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Share by Type (2021-2026)
Figure 39. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Share Forecast by Type (2027-2032)
Figure 40. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Share by Application (2021-2026)
Figure 41. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Share Forecast by Application (2027-2032)
Figure 42. North America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Type (2021-2032)
Figure 43. North America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Application (2021-2032)
Figure 44. North America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Country (2021-2032)
Figure 45. United States Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 46. Canada Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 47. Mexico Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 48. Europe Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Type (2021-2032)
Figure 49. Europe Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Application (2021-2032)
Figure 50. Europe Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Country (2021-2032)
Figure 51. Germany Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 52. France Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 53. United Kingdom Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 54. Russia Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 55. Italy Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 56. Asia-Pacific Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Type (2021-2032)
Figure 57. Asia-Pacific Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Application (2021-2032)
Figure 58. Asia-Pacific Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Region (2021-2032)
Figure 59. China Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 60. Japan Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 61. South Korea Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 62. India Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 63. Southeast Asia Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 64. Australia Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 65. South America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Type (2021-2032)
Figure 66. South America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Application (2021-2032)
Figure 67. South America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Country (2021-2032)
Figure 68. Brazil Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 69. Argentina Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 70. Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Type (2021-2032)
Figure 71. Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Application (2021-2032)
Figure 72. Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Country (2021-2032)
Figure 73. Turkey Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 74. Saudi Arabia Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 75. UAE Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 76. Killer-cell immunoglobulin-like receptors (KIRs) Market Drivers
Figure 77. Killer-cell immunoglobulin-like receptors (KIRs) Market Restraints
Figure 78. Killer-cell immunoglobulin-like receptors (KIRs) Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Killer-cell immunoglobulin-like receptors (KIRs) Industrial Chain
Figure 81. Methodology
Figure 82. Research Process and Data Source
Figure 1. Killer-cell immunoglobulin-like receptors (KIRs) Picture
Figure 2. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Type in 2025
Figure 4. KIR Genotyping Products and Services
Figure 5. KIR/CD158 Antibodies and Flow Cytometry Reagents
Figure 6. Recombinant KIR Proteins and Related Research Reagents
Figure 7. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Target Structure, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Target Structure in 2025
Figure 9. 2D KIR Products
Figure 10. 3D KIR Products
Figure 11. Pan-KIR or Mixed KIR Panel Products
Figure 12. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Function, (USD Million), 2021 & 2025 & 2032
Figure 13. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Function in 2025
Figure 14. Inhibitory KIR-related Products
Figure 15. Activating KIR-related Products
Figure 16. Mixed KIR Panel Products
Figure 17. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 18. Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Application in 2025
Figure 19. Medical Science Picture
Figure 20. Experiment Picture
Figure 21. Other Picture
Figure 22. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 23. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 24. Global Market Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 25. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Region (2021-2032)
Figure 26. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Region in 2025
Figure 27. North America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 28. Europe Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 29. Asia-Pacific Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 30. South America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 31. Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 32. Company Three Recent Developments and Future Plans
Figure 33. Global Killer-cell immunoglobulin-like receptors (KIRs) Revenue Share by Players in 2025
Figure 34. Killer-cell immunoglobulin-like receptors (KIRs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 35. Market Share of Killer-cell immunoglobulin-like receptors (KIRs) by Player Revenue in 2025
Figure 36. Top 3 Killer-cell immunoglobulin-like receptors (KIRs) Players Market Share in 2025
Figure 37. Top 6 Killer-cell immunoglobulin-like receptors (KIRs) Players Market Share in 2025
Figure 38. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Share by Type (2021-2026)
Figure 39. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Share Forecast by Type (2027-2032)
Figure 40. Global Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Share by Application (2021-2026)
Figure 41. Global Killer-cell immunoglobulin-like receptors (KIRs) Market Share Forecast by Application (2027-2032)
Figure 42. North America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Type (2021-2032)
Figure 43. North America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Application (2021-2032)
Figure 44. North America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Country (2021-2032)
Figure 45. United States Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 46. Canada Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 47. Mexico Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 48. Europe Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Type (2021-2032)
Figure 49. Europe Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Application (2021-2032)
Figure 50. Europe Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Country (2021-2032)
Figure 51. Germany Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 52. France Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 53. United Kingdom Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 54. Russia Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 55. Italy Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 56. Asia-Pacific Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Type (2021-2032)
Figure 57. Asia-Pacific Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Application (2021-2032)
Figure 58. Asia-Pacific Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Region (2021-2032)
Figure 59. China Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 60. Japan Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 61. South Korea Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 62. India Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 63. Southeast Asia Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 64. Australia Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 65. South America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Type (2021-2032)
Figure 66. South America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Application (2021-2032)
Figure 67. South America Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Country (2021-2032)
Figure 68. Brazil Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 69. Argentina Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 70. Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Type (2021-2032)
Figure 71. Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Application (2021-2032)
Figure 72. Middle East & Africa Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value Market Share by Country (2021-2032)
Figure 73. Turkey Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 74. Saudi Arabia Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 75. UAE Killer-cell immunoglobulin-like receptors (KIRs) Consumption Value (2021-2032) & (USD Million)
Figure 76. Killer-cell immunoglobulin-like receptors (KIRs) Market Drivers
Figure 77. Killer-cell immunoglobulin-like receptors (KIRs) Market Restraints
Figure 78. Killer-cell immunoglobulin-like receptors (KIRs) Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Killer-cell immunoglobulin-like receptors (KIRs) Industrial Chain
Figure 81. Methodology
Figure 82. Research Process and Data Source
